OABI - Bathi sadurunge bunga, pajak, lan amortisasi OmniAb

Logo grafis OmniAb (OABI)

OmniAb, Inc. (OABI) is scaling its B2B antibody discovery service to increase licensing payments. The GURU.Markets interface displays this chart, where calculated EBITDA visualizes operational efficiency, and 0.00 reflects the latest metric value. This price action is constrained by geopolitical barriers to technology transfer and the risk that partners may fail to achieve commercial success for their drugs amid fierce internal competition among pharma behemoths.

Bathi operasional sadurunge ngurangi amortisasi: OmniAb Inc. (OABI) kanggo 23.11.2025 - 15.11.2026

Ringkesan rincian data analitis omniab.com (OABI)

- rega saiki lan proyeksi nilai saham:
Rega OmniAb, Inc.|OABI - Prakiraan konsensus analis
- statistik kapitalisasi pasar:
Nilai pasar OmniAb Inc.|OABI - Nilai Total Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Saham OmniAb|OABI - Aset Bersih Perusahaan|Multiplikator Kapitalisasi Pasar marang Nilai Buku omniab.com|OABI - Aset Agregat Perusahaan
- data tingkat utang lan likuiditas finansial:
Koefisien Total Utang marang Modal OmniAb, Inc.|OABI - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal OmniAb Inc|OABI - Utang perusahaan|Utang marang nilai buku OmniAb Inc.|OABI - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan OmniAb|Koefisien jangkoan perantara omniab.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
OABI - Bathi resik|Proyeksi bathi mangsa ngarep OmniAb, Inc.|OABI - Pangali P/E|Rega marang bathi mangsa ngarep OmniAb Corp|OABI - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan OmniAb, Inc.|OABI - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan OmniAb|OABI - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan omniab.com|OABI - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep OmniAb, Inc.
- indikator dodolan lan pendapatan:
OABI - Dodolan perusahaan|Dodolan mangsa ngarep perusahaan omniab.com|OABI - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep OmniAb, Inc.|OABI - Wutah dodolan YoY (TTM)
Analisis kabeh metrik perusahaan:OABI - omniab.com
Produk mawa merek OmniAb, Inc.

For OmniAb, Inc., which invests in high-tech OmniClick platforms, operating profit reflects the efficiency of monetizing scientific developments before deducting financial and tax obligations. By analyzing the EBITDA_Co level on this chart, an investor assesses the net cash flow from core operations, allowing for the separation of the biopharmaceutical business's actual operational productivity from the impact of debt load and asset depreciation.

Pesaing OmniAb, Inc. (OABI)

iqvia.com (IQV) - Bathi sadurunge bunga, pajak, lan amortisasi|LH: Bathi operasional sadurunge ngurangi amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Medpace Holdings|ICON Public (ICLR) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CRL: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi evotec.com|FTRE (fortrea.com) - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Lifecore (LFCR)|Pendapatan operasional sadurunge ngurangi amortisasi Inotiv|Bathi operasional EBITDA CDMO (Avid Bioservices Inc.)|CTLT - Bathi operasional sadurunge ngurangi amortisasi|nighthawkbio.com - Bathi operasional EBITDA